NEWS - 30 November 2009

Rights Issue 100% subscribed

InferMed Finance Director, Linda Montgomery, announced that the recent rights issue was 100% subscribed. Over the last two years, InferMed has completely updated both Arezzo and MACRO product lines. “We asked our shareholders to provide additional working capital, and are delighted that they ended up competing to buy the shares on offer. This is a powerful vote of confidence in InferMed’s strategy, in our updated products, and in the management team“, said Mrs Montgomery.

If you wish to receive further information on this news item, please contact us

Click here to return to the InferMed site